New appointment at ProChon Biotech
This article was originally published in Scrip
ProChon Biotech, a US company focused on tissue regenerative technologies that are being developed to relieve pain and restore mobility for sufferers of articular cartilage injuries, has named Brian Callahan executive vice-president of regulatory and quality affairs. He was previously founder and principle of EEC & Associates, a consulting firm for the medical device, pharmaceutical and biologics industries. Before that, Mr Callahan served on the senior management teams at Quintiles Transnational and Organogenesis.